STARPHARMA HLDGS (SPHRY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 58 131 sessions, October 2, 2025 to October 2, 2026
- Largest daily move
- +26.8% close of February 11, 2026
- 1-year change
- +145.6% closing prices, October 2, 2025 to October 2, 2026
- 1-month change
- -4.7% closing prices, August 28, 2026 to October 2, 2026
Company Description
STARPHARMA HLDGS (OTC: SPHRY) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $37.2M.
SPHRY has gained 145.6% over the past year. The last closing price was $5.05.
This page collects what Stock Titan holds for SPHRY, including price data, latest news, and short interest trends.
Stock Performance
STARPHARMA HLDGS (SPHRY) closed at $5.05 on October 2, 2026. Over the past 12 months, the price has gained 145.6%.
SPHRY Metrics & Rankings
Price returns through October 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
STARPHARMA HLDGS has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all SPHRY news →
SEC Filings
Short Interest History
Short interest in STARPHARMA HLDGS (SPHRY) currently stands at 1 shares, down 99.0% from the previous reporting period. Since October 2025, short interest has decreased by 99.5%.
Days to Cover History
Days to cover for STARPHARMA HLDGS (SPHRY) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
SPHRY Company Profile & Sector Positioning
STARPHARMA HLDGS (SPHRY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing SPHRY often look at related companies in the same sector, including POOLBEG PHARMA PLC (POLBF), SERNOVA BIOTHERAPEUTICS (SEOVF), MINDMAZE THRAPEUTICS HLDS (RLFTF), MINDMAZE THERAPUTCS (RLFTY), and COVALON TECHS LTD (CVALF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SPHRY's relative position within its industry.